Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 461 - 480 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23 24  25 »
Reset 

VIRBAC: Building on the momentum of the second half of 2023, strong first-quarter revenue growth of +10.8% at constant exchange rates

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Virbac SA

OSE Immunotherapeutics’ Global License to Develop a Novel Monoclonal Antibody for the Treatment of Chronic Inflammation Becomes Effective

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  OSE Immunotherapeutics SA

Resolutions of the Annual General Meeting 2024 of Bavarian Nordic A/S

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Bavarian Nordic A/S

CARBIOS wins "So French So Innovative" award at InnoEX 2024, Hong Kong, recognizing French innovation in Asia Pacific

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Carbios SA

Growth of 28% of 2024 first quarter revenue

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Spineway

Tomorrow Capital spearheads $2.7 MN investment round in VitusCare - 'Bharat' focused kidney care start-up

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024

Mabwell Releases Preclinical Study Results of Multiple Innovative Drugs Released at the 2024 AACR Annual Meeting

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024
Related companies:  Mabwell Biotech Co.,Ltd.

Kind Pharmaceuticals Announces Settlement

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024
Related companies:  Kind Pharmaceuticals LLC

Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024

AHP Backed Prolerity Clinical Research Appoints Drew Domescik as CFO

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024

Chimeron Bio receives NIH (NCI) Innovative Concept Award for mRNA cancer vaccine development

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024
Related companies:  Chimeron Bio

March of Dimes Awards Two Basil O'Connor Grants to Study Triggers of Labor Onset, Barriers to Postpartum Heart Health

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024

Rizing Tide Foundation Unveils New Employer Connect Program

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024

Jericho Project Looks to the Future in Celebrate! 2024 Empowering Tomorrow - Gala for Change

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024

YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024

PRESBYTERIAN HEALTH PLAN AND NEW MEXICO ONCOLOGY HEMATOLOGY CONSULTANTS PARTNER ON NEW CONTRACT TO EXPAND ACCESS TO CARE

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024

Honor the Gift Coalition Raises Alarm as Transplant Clinicians Urge Medicare to Remove Restrictions on Lifesaving Diagnostic Tests as More Patients Experience Organ Rejection Episodes

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024

Ophelia Designated as Pennsylvania's First Virtual-Oriented Center of Excellence for Opioid Use Disorder Treatment

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024

Unchained Labs floats into LNP production, launches GMP-ready Sunbather!

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024
Related companies:  Unchained Labs Inc.

Encore Medical Device Repair Introduces Robotic Remanufacturing and Sustainability Program at HSPA

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23 24  25 »
to the top ↑